Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Fernandez-Banet

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|November 19, 2011
The BioSample Database (BioSD) at the European Bioinformatics InstituteMikhail Gostev, Adam Faulconbridge, Marco Brandizi, et al.
Bioinformatics (Oxford, England)|December 21, 2010
SAIL--a software system for sample and phenotype availability across biobanks and cohortsMikhail Gostev, Julio Fernandez-Banet, Johan Rung, et al.
Molecular Biology and Evolution|May 10, 2011
The origins, evolution, and functional potential of alternative splicing in vertebratesJonathan M Mudge, Adam Frankish, Julio Fernandez-Banet, et al.
Nature Methods|December 31, 2015
OASIS: web-based platform for exploring cancer multi-omics dataJulio Fernandez-Banet, Anthony Esposito, Scott Coffin, et al.
Genomics|January 28, 2014
Decoding complex patterns of genomic rearrangement in hepatocellular carcinomaJulio Fernandez-Banet, Nikki P Lee, Kin Tak Chan, et al.
Molecular Cancer Therapeutics|March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor TherapyDavid M Briere, Shuai Li, Andrew Calinisan, et al.
Database : the Journal of Biological Databases and Curation|June 25, 2016
The Ensembl gene annotation systemBronwen L Aken, Sarah Ayling, Daniel Barrell, et al.
Nature Communications|May 2, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signaturesZhengyan Kan, Ying Ding, Jinho Kim, et al.
Nature Medicine|October 10, 2022
Anti-tumor efficacy of a potent and selective non-covalent KRAS<sup>G12D</sup> inhibitorJill Hallin, Vickie Bowcut, Andrew Calinisan, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|November 19, 2011
The BioSample Database (BioSD) at the European Bioinformatics InstituteMikhail Gostev, Adam Faulconbridge, Marco Brandizi, et al.
Bioinformatics (Oxford, England)|December 21, 2010
SAIL--a software system for sample and phenotype availability across biobanks and cohortsMikhail Gostev, Julio Fernandez-Banet, Johan Rung, et al.
Molecular Biology and Evolution|May 10, 2011
The origins, evolution, and functional potential of alternative splicing in vertebratesJonathan M Mudge, Adam Frankish, Julio Fernandez-Banet, et al.
Nature Methods|December 31, 2015
OASIS: web-based platform for exploring cancer multi-omics dataJulio Fernandez-Banet, Anthony Esposito, Scott Coffin, et al.
Genomics|January 28, 2014
Decoding complex patterns of genomic rearrangement in hepatocellular carcinomaJulio Fernandez-Banet, Nikki P Lee, Kin Tak Chan, et al.
Molecular Cancer Therapeutics|March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor TherapyDavid M Briere, Shuai Li, Andrew Calinisan, et al.
Database : the Journal of Biological Databases and Curation|June 25, 2016
The Ensembl gene annotation systemBronwen L Aken, Sarah Ayling, Daniel Barrell, et al.
Nature Communications|May 2, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signaturesZhengyan Kan, Ying Ding, Jinho Kim, et al.
Nature Medicine|October 10, 2022
Anti-tumor efficacy of a potent and selective non-covalent KRAS<sup>G12D</sup> inhibitorJill Hallin, Vickie Bowcut, Andrew Calinisan, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Pageof 2